Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 30,418Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Merck Canada Inc.

02 2Organon Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Asenapine Maleate

Brand Name : SAPHRIS

Patent Number : 2603509

Filing Date : 2006-04-06

Strength per Unit : 5 mg

Dosage Form : tablet

Human Or VET : Human

Route of Administration : sublingual

Patent Expiration Date : 2026-04-06

Date Granted : 2013-12-03

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Asenapine Maleate

Brand Name : SAPHRIS

Patent Number : 2182981

Filing Date : 1995-03-01

Strength per Unit : 5 mg

Dosage Form : tablet

Human Or VET : Human

Route of Administration : sublingual

Patent Expiration Date : 2015-03-01

Date Granted : 2006-10-17

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Asenapine Maleate

Brand Name : SAPHRIS

Patent Number : 2603509

Filing Date : 2006-04-06

Strength per Unit : 10 mg

Dosage Form : tablet

Human Or VET : Human

Route of Administration : sublingual

Patent Expiration Date : 2026-04-06

Date Granted : 2013-12-03

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Asenapine Maleate

Brand Name : SAPHRIS

Patent Number : 2182981

Filing Date : 1995-03-01

Strength per Unit : 10 mg

Dosage Form : tablet

Human Or VET : Human

Route of Administration : sublingual

Patent Expiration Date : 2015-03-01

Date Granted : 2006-10-17

blank